Antimicrobial resistance of gram-negative pathogens isolated from hospitalized patients in Rostov region
-
Published:2020
Issue:2
Volume:22
Page:143-148
-
ISSN:2686-9586
-
Container-title:Clinical Microbiology and Antimicrobial Chemotherapy
-
language:ru
-
Short-container-title:CMAC
Author:
Kutsevalova Olga Yu.1, Kozel Yu.Yu.1, Rozenko D.A.1, Martynov D.V.2, Korshunkova O.V.3
Affiliation:
1. National Medical Research Centre of Oncology, Rostov-on-Don, Russia 2. Rostov State Medical University, Rostov-on-Don, Russia 3. Central City Hospital, Azov, Russia
Abstract
Objective.
To evaluate resistance rates to carbapenems and III–IV generation cephalosporins among gramnegative bacteria, including production of carbapenemases and extended-spectrum beta-lactamases (ESBL).
Materials and Methods.
A total of 460 gram-negative bacteria isolated from hospitalized patients aged 1 to 85 years from 8 medical institutions of Rostov-on-Don and the region from April 2018 to December 2019 were tested by conventional microbiological methods. The most common acquired carbapenemases genes were determined by real-time PCR using commercial kits (Central Research Institute of Epidemiology, Russia).
Results.
The tested isolates included 180 (39.1%) isolates of K. pneumoniae, 87 (18.9%) – E. coli, 101 (22.0%) – A. baumannii and 92 (20.0%) – P. aeruginosa. K. pneumoniae and E. coli isolates exhibited the high resistance rates to cefotaxime – 96.7% and 71.2%, to ceftazidime – 95.5% and 54.0%, and to cefepime – 95.5% and 54.0%, respectively. ESBL production was detected in 35.0% and 78.2% of K. pneumoniae and E.coli isolates, respectively. K. pneumoniae and E. coli isolates were resistant to imipenem, meropenem, and ertapenem: 57.8% and 3.4%; 55.0% and 2.3%; 60.0% and 4.6%, respectively. Carbapenemase production was detected in 27.8% of K. pneumoniae and 4.6% of E. coli isolates. The most common beta-lactamases were metallo-beta-lactamases (NDM) and serine carbapenemases (OXA-48). A. baumannii isolates showed the high resistance rates to imipenem and meropenem (87.1% and 85.1%). The most common beta-lactamases were metallo-beta-lactamases (NDM) and serine carbapenemases (OXA-24⁄40 and OXA-23). P. aeruginosa isolates also showed the high resistance to carbapenems – imipenem (61.9%) and meropenem (58.7%). The most common betalactamases were metallo-beta-lactamases (VIM) and GES-5.
Conclusions.
The results of this microbiological study indicate the extremely high prevalence of aerobic gram-negative bacteria in different infections. A. baumannii, P. aeruginosa, K. pneumoniae and E. coli isolates being resistant to third- and fourth-generation cephalosporins and carbapenems are particularly dangerous, especially due to production of ESBL and carbapenemases. The most clinically important are OXA and NDM beta-lactamases.
Publisher
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Epidemiology
Reference20 articles.
1. Alyokhin A.V., Arutyunov G.P., Bagnenko S.F., Bayalieva A.Zh., Zhuravleva M.V., Kaprin A.D., et al. Council of experts resolution on the use of inhibitor-protected beta-lactams in the treatment of community-acquired and nosocomial infections, 11 February, 2019, Moscow. Antibiotiki i himioterapija. 2019;64(1-2):34-36. Russian. DOI: 10.24411/0235W2990W2019W10006 2. Edelstein M.V., Shek E.A., Sukhorukova M.V., Skleenova E.Yu., Ivanchik N.V., Shajdullina E.R., Mikotina A.V., Kuzmenkov A.Yu., Dekhnich A.V., Kozlov R.S., Semyonova N.V., Slepakova S.A., Shepotajlova N.V., Strebkova V.V., Rybina N.A., Yaranceva N.Z., Perevalova E.Yu., Rozanova S.M., Nagovicina S.G., Moldovanu M.G., Nasybullova Z.Z., Arkhipenko M.V., Shakhmuradyan R.M., Nizhegorodceva I.A., Varibrus E.V., Aleksandrova I.A., Lazareva A.V., Kryzhanovskaya O.A., Markelova N.N., Chernyavskaya Yu.L., Lebedeva E.V., Kirillova G.Sh., Bekker G.G., Popova L.D., Elokhina E.V., Smol’kova Yu.E., Zinov’ev D.Yu., Ityaeva L.N., Blinova G.Yu., Zubareva N.A., Vityazeva V.P., Plaksina M.G., Kucevalova O.Yu., Panova N.I., Suborova T.N., Polukhina O.V., Voroshilova T.M., Churikova E.M., Moskvitina E.N., Krechikova O.I., Petrova T.A., Mart’yanova N.M., Khokhlova K.O., Gudkova L.V., Bykonya S.A., Khokhlyavina R.M., Shpil’kina L.V., Burasova E.G., Khrebtovskaya V.A., Molchanova I.V., Zvonaryova O.V., Kornilova P.A., Kryanga V.G., Portnyagina U.S., Shamaeva S.Kh., Popov D.A., Vostrikova T.Yu. Antimicrobial resistance, carbapenemase production and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study «MARATHON 2015-2016».Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2019;21(2):160-170. Russian. DOI: 10.36488/cmac.2019.2.160-170 3. Sukhorukova M.V., Edelstein M.V., Skleenova E.Yu., Ivanchik N.V., Shajdullina E.R., Mikotina A.V., Azyzov I.S., Shek E.A., Kuzmenkov A.Yu., Dekhnich A.V., Kozlov R.S., Semyonova N.V., Slepakova S.A., Shepotajlova N.V., Strebkova V.V., Rybina N.A., Yaranceva N.Z., Perevalova E.Yu., Rozanova S.M., Nagovicina S.G., Moldovanu M.G., Nasybullova Z.Z., Arkhipenko M.V., Shakhmuradyan R.M., Nizhegorodceva I.A., Varibrus E.V., Aleksandrova I.A., Lazareva A.V., Kryzhanovskaya O.A., Markelova N.N., Chernyavskaya Yu.L., Lebedeva E.V., Kirillova G.Sh., Bekker G.G., Popova L.D., Elokhina E.V., Smol’kova Yu.E., Zinov’ev D.Yu., Ityaeva L.N., Blinova G.Yu., Zubareva N.A., Vityazeva V.P., Plaksina M.G., Kucevalova O.Yu., Panova N.I., Suborova T.N., Polukhina O.V., Voroshilova T.M., Churikova E.M., Moskvitina E.N., Krechikova O.I., Petrova T.A., Mart’yanova N.M., Khokhlova K.O., Gudkova L.V., Bykonya S.A., Khokhlyavina R.M., Shpil’kina L.V., Burasova E.G., Khrebtovskaya V.A., Molchanova I.V., Zvonaryova O.V., Kornilova P.A., Kryanga V.G., Portnyagina U.S., Shamaeva S.Kh., Popov D.A., Vostrikova T.Yu. Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015-2016”. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2019;21(2):147-159. Russian. DOI: 10.36488/cmac.2019.2.147-159 4. Shek E.A., Sukhorukova M.V., Edelstein M.V., Skleenova E.Yu., Ivanchik N.V., Shajdullina E.R., Mikotina A.V., Kuzmenkov A.Yu., Dekhnich A.V., Kozlov R.S., Semyonova N.V., Slepakova S.A., Shepotajlova N.V., Strebkova V.V., Rybina N.A., Yaranceva N.Z., Perevalova E.Yu., Rozanova S.M., Nagovicina S.G., Moldovanu M.G., Nasybullova Z.Z., Arkhipenko M.V., Shakhmuradyan R.M., Nizhegorodceva I.A., Varibrus E.V., Aleksandrova I.A., Lazareva A.V., Kryzhanovskaya O.A., Markelova N.N., Chernyavskaya Yu.L., Lebedeva E.V., Kirillova G.Sh., Bekker G.G., Popova L.D., Elokhina E.V., Smol’kova Yu.E., Zinov’ev D.Yu., Ityaeva L.N., Blinova G.Yu., Zubareva N.A., Vityazeva V.P., Plaksina M.G., Kucevalova O.Yu., Panova N.I., Suborova T.N., Polukhina O.V., Voroshilova T.M., Churikova E.M., Moskvitina E.N., Krechikova O.I., Petrova T.A., Mart’yanova N.M., Khokhlova K.O., Gudkova L.V., Bykonya S.A., Khokhlyavina R.M., Shpil’kina L.V., Burasova E.G., Khrebtovskaya V.A., Molchanova I.V., Zvonaryova O.V., Kornilova P.A., Kryanga V.G., Portnyagina U.S., Shamaeva S.Kh., Popov D.A., Vostrikova T.Yu. Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study “MARATHON 2015-2016”. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2019;21(2):171-180. Russian. DOI: 10.36488/cmac.2019.2.171-180 5. TOWARDS ACCESS 2030. WHO Medicines and Health Products Programme Strategic Framework 2016-2030. P. 34. Available at: www.who.int/medicines/publications/towards_access2030/en/. Accessed June 1, 2020.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|